Emylcamate

Emylcamate

File:Emylcamate.png
Clinical data
ATC code	N05BC03 (WHO)
Identifiers
IUPAC name 3-methyl-3-pentanol carbamate
CAS Number	78-28-4
PubChem CID	6526
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C7H15NO2
Molar mass	145.20 g·mol−1

Emylcamate (marketed as Striatran® by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed.

References

• Olhando para trás: um novo caminho possível para a descoberta de drogas em psicofarmacologia (Portuguese)
• The Comparative Toxicogenomics Database: Emylcamate.
• BIAM: Emylcamate (French).

Template:Pharma-stub Template:Anxiolytics